Modeling Congenital Hyperinsulinism with ABCC8-Deficient Human Embryonic Stem Cells Generated by CRISPR/Cas9
Abstract Congenital hyperinsulinism (CHI) is a rare genetic disorder characterized by excess insulin secretion, which results in hypoglycemia. Mutation of sulfonylurea receptor 1 (SUR1), encoded by the ABCC8 gene, is the main cause of CHI. Here, we captured the phenotype of excess insulin secretion...
Guardado en:
Autores principales: | Dongsheng Guo, Haikun Liu, Aynisahan Ruzi, Ge Gao, Abbas Nasir, Yanli Liu, Fan Yang, Feima Wu, Guosheng Xu, Yin-xiong Li |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/2eef6fa0dafc4b3492d08947d95ff76c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
ABCC6 deficiency promotes dyslipidemia and atherosclerosis
por: Christopher Brampton, et al.
Publicado: (2021) -
Health-Related Quality of Life of Children and Adolescents With Congenital Hyperinsulinism – A Scoping Review
por: Kaja Kristensen, et al.
Publicado: (2021) -
Mutations in UCP2 in congenital hyperinsulinism reveal a role for regulation of insulin secretion.
por: M Mar González-Barroso, et al.
Publicado: (2008) -
Transient congenital hyperinsulinism and hemolytic disease of a newborn despite rhesus D prophylaxis: a case report
por: Sandra Simony Tornoe Riis, et al.
Publicado: (2021) -
Whole genome SNP genotyping and exome sequencing reveal novel genetic variants and putative causative genes in congenital hyperinsulinism.
por: Maria Carla Proverbio, et al.
Publicado: (2013)